Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Lilly. "We're committed to expanding access to treatment options through channels that meet patients where they are and help them achieve their weight loss goals." Ro's obesity care formulary is one the most comprehensive of any telehealth company,...

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

beat-to-beat arterial waveform data from a noninvasive finger cuff directly to compatible multiparameter patient monitors, helping clinicians close gaps between intermittent readings. "We're delivering real-time visibility of hemodynamic changes to...

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

Curve Biosciences is advancing innovative approaches designed to shift that paradigm. I am excited to join the team and help translate scientific innovation into practical tools that can improve survival and quality of life for patients with liver...

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

invasive, long-lifetime “read/write” brain-computer interface (BCI) with assistive devices and AI-driven support to help stroke survivors translate neural intent into functional movement and daily independence. Epia Neuro is advancing towards...

Tiger BioSciences Launched carePAC™: Pre-Configured Wound Care Kits for Simplified At-Home Management

stop when a patient leaves the clinic," said Garrett Grinsfelder, President of Tiger Wound Care. "With carePAC™, we are helping bridge the gap between the clinical setting and the home by delivering convenient, pre-configured kits that simplify the...

Thermo Fisher Scientific Unveils Integrated Platform to Enhance Biologics Development

cultures, establishing stable pools in as little as four weeks, and supporting selection of stable clones within 14 weeks, helping to streamline progression from early development to commercial manufacturing. “Biologics developers face increasing...

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

whose leadership, extensive experience in rare diseases and strong knowledge of the French healthcare landscape, will help us establish a high-impact operation and expand access to innovative orphan medicines.” Constance brings vast expertise in...

Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

Neuroinvestment’s CEO of the Year and received the Burke Award from Burke Rehabilitation Hospital for his contributions to helping people with disabilities gain independence. He has been recognized by the NYBA as its “The Cures Start Here” Business...

ulrich medical USA® Expands Commitment to Evidence-Based Spine Innovation; Appoints Alissa Calaway, RN, MSN as Director of U.S. Clinical Affairs

with the spine community," said Eric Lucas, PhD, Global Vice President of R&D, Spine for ulrich medical. "Clinical data helps us support surgeons and deliver technologies that improve patient outcomes with confidence." About ulrich medical USA...

Eton Pharmaceuticals Strengthens Rare Disease Portfolio with U.S. Commercialization Rights to HEMANGEOL® Oral Solution

benefits investigation, educational support, financial assistance for qualified patients, and other services designed to help patients access treatment. Eton Cares will offer co-pay assistance with $0 co-pay for qualifying patients. Do not give...

30% Lower Risk With WELIREG® + LENVIMA® vs. Cabozantinib in Previously Treated RCC

are diagnosed at an advanced stage. About Merck’s research in genitourinary cancers Merck is advancing research aimed at helping transform the treatment landscape and broaden options for people with genitourinary (GU) cancers, including bladder,...

Unique Mouse Model Enables genOway to Transform Prediction of Antibody Therapies in Humans

A new study published in Science Immunology showed that an innovative mouse model developed by genOway, genO-hFcγR, helps scientists better predict the efficacy and safety of therapeutic antibodies in humans. The model allows scientists to rank...

ARUP Laboratories Establishes Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

concepts outside of routine clinical workflows. ARUP offers a full suite of services and full life cycle management to help partners accelerate innovation and get products to market efficiently and effectively. The launch of the Innovation Central...

ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

and an investigator for the SMART clinical trial. “These new findings from SMART demonstrate the potential of ENFLONSIA to help protect these vulnerable children, who may require an additional dose for their second RSV season.” Interim data from...

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

expands and global regulatory expectations evolve. Emma's depth of experience in evidence and modelling will be pivotal in helping our clients navigate these pressures and strengthen their market access strategy," said Jake Graetz, Chief Business...

A Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression.

our long-held hypothesis that deuterium depletion can exert anticancer effects at the sub-molecular level." These findings help explain earlier results, where data from 2,649 cancer patients who drank DDW showed that adding DDW to regular...

China approves Libevitug, first-in-class therapy for hepatitis D

rates for viral hepatitis and reduce the incidence of liver cancer and mortality. We anticipate that Libevitug will help effectively lower the risk of disease progression to advanced severe diseases such as liver cancer, drive the standardization...

HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline

commitment to quality, we strive to accelerate the development of HanchorBio's innovative bi-/multi fusion proteins and help bring transformative therapies to patients worldwide. About HanchorBio Based in Taipei, Shanghai, and the San Francisco Bay...

BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

announced the immediate availability of its new Bruise Care System. The innovative dual-approach regimen is designed to help patients prepare for and recover more quickly from cosmetic and surgical procedures, including injections, dermal fillers,...

First National Campaign Launched by Trauma Intervention Programs (TIP)

TIP to elevate that mission nationally, and the leadership of board members like Maryam Parman has been instrumental in helping TIP reach this moment. "Our services are unique because we focus on the immediate emotional aftermath—helping survivors...